On July 18, 2025, at “The 4th International Green Zero-Carbon Festival & 2025 ESG Leadership Summit” held in Shanghai, China Medical System Holdings Limited (“CMS” or “the Group”) was honored with the “2025 ESG Exemplary Enterprise Award”. This award recognizes enterprises demonstrating systematic and pioneering practices across environmental, social, and governance dimensions. With its clear ESG strategy framework, quantifiable results, and continuous improvement mechanism, CMS has once again been highly recognized by authoritative institutions and the industry.
Source: International Green Zero-Carbon Festival Official Website
With the theme of “Advancing Green Development, Toward Zero-Carbon Future”, the summit brought together over 200 enterprises and more than 100 industry leaders to discuss the industrial opportunities and transformation pathways under the dual carbon goal. This award is a full recognition of CMS’s long-term commitment to ESG values and innovation-driven sustainable development.
CMS has fully integrated the United Nations Sustainable Development Goals (SDGs) into the Group’s strategy, using top-level design to drive sustainability across the entire value chain. The Group focuses on unmet clinical needs through pharmaceutical innovation, and constantly empowers the transformation of scientific research outcomes into enhanced clinical practice, improving the accessibility and affordability of pharmaceutical products. The Group also continuously invests in public welfare and charitable undertakings, achieving the symbiotic growth of corporate value and societal well-being. At the same time, the Group fosters a diverse, inclusive, healthy, and safe workplace, adheres to green and low-carbon operations, and collaborates with partners to build a sustainable supply chain.
The Group’s ESG performance has been recognized by authoritative domestic and international rating agencies:
- MSCI ESG ratingmaintains “AA”;
- S&P CSA scoreis 61, outperforming 93% of global peers;
- HKQAA Sustainability Rating is in the top 10% of the industry;
- Wind ESG rating is“AA”.
In addition, on May 16th, at the “2025 Taihu Bay Future Healthcare Conference” hosted by Wuxi Municipal People’s Government and supported by Healthcare Executive(“E药经理人”) and other organizations, CMS was awarded the “Biopharmaceutical Sustainable Business Pioneer Award”. Moving forward, CMS will continue to be an active promoter and firm practitioner of sustainable development, deepen the layout and implementation of ESG strategy, and join hands with global partners and other stakeholders to create a healthy, low-carbon, and sustainable ecosystem.
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.